Diabetes Dialogue: STEP-HFpEF Reaction

Less than 2 weeks after the release of their SELECT reaction podcast, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down for a special edition episode of Diabetes Dialogue to discuss STEP-HFpEF data and the implications for semaglutide 2.4 mg.

Related Keywords

United States ,America ,Natalie Bellini ,Diana Isaacs ,Training In Diabetes Technology ,Diabetes Technology At University Hospitals ,European Society Of Cardiology ,Metabolic Care Center ,Novo Nordisk ,European Society ,New England Journal ,South America ,Kansas City Cardiomyopathy Questionnaire ,Diabetes Technology ,Endocrine Disorders ,Cleveland Clinic ,University Hospitals Diabetes ,Diabetes Dialogue ,Real World Perspectives ,Heart Failure ,Preserved Ejection Fraction ,Esc Congress 2023 ,Esc Congress ,Step Hfpef ,Semaglutide 2 4 Mg ,Semaglutide 2 4 Mg Wegovy ,Wegovy ,